Palexia® (tapentadol hydrochloride)

Lynn Lambert

Abstract


Palexia® is an analgesic containing the active ingredient tapentadol hydrochloride.1,2 Tapentadol is a novel, dual-acting central analgesic working as a mμ-opioid receptor (MOR) agonist and noradrenaline reuptake inhibitor (NRI).3,4

Keywords


Palexia®

Full Text:

PDF



This journal is hosted by: Medpharm Publications. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 South Africa License